Repository logo
 

Advances in Targeting Signal Transduction Pathways

This item will be available on:

Authors

McCubrey, James A.
Steelman, Linda S.
Chappell, William H.
Sun, Lin
Davis, Nicole Marie
Abrams, Stephen L.
Franklin, Richard A.
Cocco, Lucio
Evangelisti, Camilla
Chiarini, Francesca

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Over the past few years, significant advances have occurred in both our understanding of the complexity of signal transduction pathways as well as the isolation of specific inhibitors which target key components in those pathways. Furthermore critical information is being accrued regarding how genetic mutations can affect the sensitivity of various types of patients to targeted therapy. Finally, genetic mechanisms responsible for the development of resistance after targeted therapy are being discovered which may allow the creation of alternative therapies to overcome resistance. This review will discuss some of the highlights over the past few years on the roles of key signaling pathways in various diseases, the targeting of signal transduction pathways and the genetic mechanisms governing sensitivity and resistance to targeted therapies.

Description

Citation

Oncotarget; 3:12 p. 1505-1521

item.page.doi